Product Details

Seebri Breezhaler

Glycopyrronium Bromide
50 mcg
Powder for Inhalation
Capsule

DIN/PIN/NPN

02394936

Manufacturer

Novartis Pharma Canada Inc.

Formulary Listing Date

2013-08-29  

Unit Price

1.8302

Amount MOH Pays

1.8302

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Seebri Breezhaler: The dose of Seebri Breezhaler should not exceed 50mcg per day.

ATC Code

R03BB06

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph